Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glial Cells01:04

Glial Cells

87.0K
Overview
87.0K
Nervous Tissue: Glial Cells01:31

Nervous Tissue: Glial Cells

2.9K
Glia, or neuroglia, are vital support cells that assist neurons in their functions. The term "glia" originates from the Greek word for "glue," reflecting their role in holding the nervous system together. These cells can be categorized into six types: four in the central nervous system (CNS) and two in the peripheral nervous system (PNS).
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

A prognostic human brain network for diffuse midline glioma.

Nature·2026
Same author

Prediction of treatment failure in patients with glioblastoma with perfusion MRI and molecular biomarkers.

Neuro-oncology advances·2026
Same author

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant Gliomas.

Neuro-oncology·2026
Same author

European neuro-oncology quality assessment (ENOQUA): A European organization for the research and treatment of cancer (EORTC) brain tumor group research project.

Neuro-oncology practice·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026
Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2025

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
05:45

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Published on: January 19, 2024

1.8K

Glioma.

Michael Weller1, Patrick Y Wen2, Susan M Chang3

  • 1Department of Neurology & Brain Tumour Center, University Hospital Zurich & University of Zurich, Zurich, Switzerland. Michael.Weller@usz.ch.

Nature Reviews. Disease Primers
|May 9, 2024
PubMed
Summary
This summary is machine-generated.

Gliomas, brain tumors originating from neural stem cells, are classified by WHO into grades 1-4. Molecular subtypes like IDH-mutant and IDH-wild-type glioblastomas define distinct prognoses and treatment strategies.

More Related Videos

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

15.8K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

12.9K

Related Experiment Videos

Last Updated: Jun 26, 2025

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
05:45

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Published on: January 19, 2024

1.8K
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

15.8K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

12.9K

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Genetics

Background:

  • Gliomas are primary brain tumors arising from genetically altered neural stem/progenitor cells.
  • WHO classification categorizes gliomas by histology and molecular features into grades 1-4.
  • Adult diffuse gliomas include IDH-mutant/1p19q-codeleted oligodendrogliomas, IDH-mutant astrocytomas, and IDH-wild-type glioblastomas, each with unique prognoses.

Purpose of the Study:

  • To provide an overview of glioma classification and characteristics.
  • To highlight the distinct clinical courses and outcomes of different glioma subtypes.
  • To emphasize the role of molecular alterations in guiding treatment strategies.

Main Methods:

  • Review of current WHO classification of CNS tumors.
  • Analysis of histological and molecular features of gliomas.
  • Summary of clinical outcomes and treatment responses for distinct glioma subtypes.

Main Results:

  • Adult gliomas are categorized into three main types based on IDH mutation and 1p/19q codeletion status, dictating prognosis.
  • Pediatric gliomas, such as pilocytic astrocytoma and diffuse midline glioma, exhibit distinct behaviors and outcomes.
  • Ependymal tumors are classified into biologically and prognostically distinct subtypes.
  • Tailored treatments targeting dominant signaling pathways improve outcomes in specific glioma patient subsets.

Conclusions:

  • Glioma classification relies on integrated histopathological and molecular data.
  • Understanding molecular drivers is crucial for predicting prognosis and personalizing treatment.
  • Advances in molecular diagnostics and targeted therapies are improving glioma patient outcomes.